Agios Pharmaceuticals | AGIO - Cost Of Sales

Agios Pharmaceuticals reported $413K in Cost of Sales for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Cost Of Sales Change
Abbvie ABBV:US USD 4.17B 57M
Agios Pharmaceuticals AGIO:US USD 413K 104K
Alnylam Pharmaceuticals ALNY:US USD 51.27M 10.15M
Amgen AMGN:US USD 1.75B 159M
Astellas Pharma 4503:JP JPY 74.42B 11.64B
AstraZeneca AZN:LN USD 2.51B 393M
Bayer BAYN:GR EUR 4.77B 521M
Biogen BIIB:US USD 570.9M 101.4M
Biomarin Pharmaceutical BMRN:US USD 127.29M 11M
Bristol Myers Squibb BMY:US USD 2.52B 167M
Daiichi Sankyo 4568:JP JPY 97.98B 13.21B
Eli Lilly And LLY:US USD 1.55B 31M
Exelixis EXEL:US USD 15.92M 615K
Gilead Sciences GILD:US USD 1.4B 1000K
GlaxoSmithKline GSK:LN GBP 2.18B 209M
IONIS PHARMACEUT IONS:US USD 3.69M 2.17M
JAZZ PHA JAZZ:US USD 167.36M 33.7M
Merk MRK:US USD 3.36B 519M
Moderna Inc MRNA:US USD 1.92B 818M
Nektar Therapeutics NKTR:US USD 6.23M 1.26M
Novartis NOVN:VX USD 3.84B 180M
Novartis NVS:US USD 3.84B 180M
Pfizer PFE:US USD 9.82B 3.73B
Puma Biotechnology PBYI:US USD 16.84M 4.34M
Regeneron Pharmaceuticals REGN:US USD 540.6M 222.8M
Roche Holding ROG:VX 8.95B 613M
Sarepta Therapeutics SRPT:US USD 30.8M 9.15M
Seattle Genetics SGEN:US USD 108.21M 88K
Vertex Pharmaceuticals VRTX:US USD 283.3M 6.1M
YTE INCY:US USD 53.76M 4.48M